Inside the 629% Surge: What Unitree's Shanghai Debut Says About Scarcity, Valuation, and China's Robot Trade

Unitree Robotics opened on the Shanghai STAR Market, 629.44% above its issue price, briefly valuing the first humanoid robotics company to list in mainland China at about $66 billion, before closing at roughly $50 billion. The retail tranche was oversubscribed more than 8,000 times, a STAR Market record, with 9.8 million accounts competing for approximately 9.7 million shares against a freely circulating float near 7.4% of share capital. Founder Wang Xingxing's 121.4 million shares were worth about 103 billion yuan at the close, and DeepSeek founder Liang Wenfeng's research vehicle took 933,399 shares under a 36-month lockup. The business underneath is real and profitable, with 2025 revenue of 1.708 billion yuan, net profit of 278.21 million yuan and a 60.27% gross margin, but the IPO priced at 219 times earnings and closed near 1,300 times, while first-half 2026 adjusted net profit is guided to fall between 6.43% and 21.97%. In late July, Washington added foreign-made humanoid and quadruped robots to the FCC Covered List, and overseas sales were about 44% of main-business revenue last year.

 

Unitree Robotics opened at 1,100 yuan on Wednesday, 629.44% above where the underwriters priced it, and for a few minutes the Hangzhou company formally registered as Yushu Technology was worth 444.9 billion yuan, roughly $66 billion. By the close it was worth 342 billion. It was produced by a genuinely extraordinary demand imbalance running against a float of about 7.4%, in a market where the average new Shanghai listing this year has opened up around 466% anyway. Underneath sits a company that is profitable, first in the world by humanoid unit shipments, and decelerating hard enough that management has guided first-half profit to shrink. This article works through the demand, the supply, who actually collected, what the financials support, and the trade restriction that sits outside every one of those calculations.

 

The subscription data explains the opening price better than any thesis about embodied intelligence. Unitree's retail tranche was oversubscribed more than 8,000 times, a record for the STAR Market, drawing total retail orders above 7.07 trillion yuan. Roughly 9.8 million retail accounts applied for approximately 9.7 million shares. The average applicant was chasing less than one share. Whoever won a single lot held a paper gain near 475,000 yuan seconds after the open. That is the mechanical result of nine million people bidding for a stack of shares small enough to fit in a few thousand hands.

The regulatory path matched the enthusiasm. The Shanghai Stock Exchange accepted the application on March 20, 2026, and the CSRC approved registration about 104 days later, the fastest turnaround in STAR Market history. CITIC Securities sponsored and led the underwriting. The offering raised 6.099 billion yuan against a 4.2 billion yuan target, selling 40.4464 million new shares equal to 10% of enlarged capital, with proceeds directed to AI model development, robot hardware research, new products and manufacturing capacity. The listing landed on the opening day of the World Robot Conference in Beijing, where Unitree drew crowds around a three-metre rideable machine that switches between bipedal and quadrupedal modes. Stephen Innes of Quintex Intel read the session as the market signalling where speculative attention is rotating next, with embodied AI as the new object of desire.

 

Ten percent of the company was offered, close to a fifth of that tranche went to strategic investors under lockups, and what remains genuinely circulating is roughly 7.4% of share capital, with some analyses putting it nearer 7.36%. When demand of the scale described above meets a supply of that size, the clearing price stops being a judgment about discounted cash flows and becomes an artifact of scarcity. The same structure produced ChangXin Memory Technologies' 466% first-day surge on the same exchange earlier this year. And the market's own baseline is instructive: with new Shanghai listings averaging first-day gains around 466%, Unitree's 460% close sits almost exactly at the norm. Anyone reading this from crypto will recognise the shape immediately. Low float against high fully diluted valuation is the same critique aimed at token launches for the last three years, and it produces the same distortion: a price discovered by a sliver tells you very little about the whole.

 

 

Wang Xingxing, 36, founded the company in 2016 and controls 68.78% of voting rights. His 121.4 million shares were worth roughly 103 billion yuan at the close, with Reuters putting his paper wealth above $12 billion. Wang sat in the front row at President Xi Jinping's symposium with senior Chinese technology executives last year, which is its own signal about where robotics sits in Beijing's industrial priorities.

The allocation drawing the most attention went to Hangzhou DeepSeek Artificial Intelligence Basic Technology Research, Liang Wenfeng's vehicle, which took 933,399 shares for about 141 million yuan, 2.31% of the offering, alongside a strategic cooperation memorandum on embodied intelligence and large models. At the opening price that position showed a gain near 886 million yuan.

It carries a 36-month lockup. So does the rest of the strategic tranche, which includes a Tencent platform, CNPC's Kunlun Capital, China Southern Power Grid's finance arm, Tianyi Capital and the National Council for Social Security Fund, several at around 0.2233% of shares with 0.11% voting rights. Among pre-IPO holders, Meituan is the largest outside investor, with Tencent, Alibaba, Ant Group, China Mobile, Geely, HongShan and Xiaomi holding through affiliates.

Which means the enormous first-day wealth was almost entirely uncollectable. Locked holders cannot sell until 2029, insiders cannot sell, the retail investors who could sell were the small minority who won an allocation.

 

Strip out the float mechanics and Unitree is a better company than most of what lists into hype cycles. Revenue went from 159 million yuan in 2023 to 392.77 million in 2024 to 1.708 billion in 2025, a 226.8% compound rate. Net profit moved from an 11.15 million yuan loss to 94.5 million to 278.21 million, on a 60.27% gross margin. Stripping non-recurring items, principally share-based payment, 2025 profit was 600.1 million yuan, which is where the higher figures in circulation come from. The company shipped more than 5,500 humanoids last year, first globally at a 32.4% share, and sold 33,294 quadrupeds and 5,632 humanoids across 2023 to 2025. Hong Kong-listed UBTech and Dobot are both still loss-making, at 37.7% and 46.1% gross margins. The IPO priced at 219 times earnings, already aggressive. At the close the stock traded near 1,300 times trailing earnings and roughly 210 times sales, for a company that earned about $41 million on $252 million of revenue.

And growth is decelerating into that multiple; First-quarter 2026 revenue rose 68.49% to 422.8 million yuan, down from 332.64% a year earlier, while adjusted net profit fell 52.55% to 40.25 million and attributable net profit fell 47.69%, weighed by a Spring Festival Gala campaign and climbing R&D and sales spend. First-half guidance is revenue growth of 35.62% to 45.41% against an adjusted net profit decline of 6.43% to 21.97%.

There is also a question the shipment numbers do not answer. Unitree sells substantially to universities and research institutions, not into the large-scale factory deployment that would justify a valuation of this size. Management frames the spending surge as a deliberate move from hardware vendor to embodied-AI platform, open-sourcing the UnifoLM-WMA-0 world model in September 2025 and releasing UnifoLM-VLA-0 in January 2026. That pivot may well be correct. It is not yet in the earnings, and the earnings are what the multiple is measured against.

 

In late July 2026 the FCC added foreign-made humanoid and quadruped robots to its Covered List on national security grounds, and Washington banned imports of new foreign-made robots. China's commerce ministry threatened countermeasures. Overseas sales were about 44% of Unitree's main-business revenue in 2025, with the United States alone at 13.3%. The prospectus names the US as a key market and flags American trade restrictions as a geopolitical risk. The company says its existing models hold US approvals; future ones could be barred. Every other risk here is a question about execution, and execution is at least partly within management's control. For a first-listed pure-play carrying several hundred times earnings, the valuation requires the addressable market to expand, and the largest Western market has just started moving the other way.

 

The questions that actually determine whether the valuation holds were not on the ballot on Wednesday, and they arrive on a schedule. The nearest is the first-half report, which will show whether the guided profit contraction reads as investment in the platform pivot or as deceleration in the underlying business. Behind it sits the commercialisation question: whether the customer base moves from universities and research institutions toward the factory deployment that a valuation of this size assumes. Further out is the 44% of main-business revenue earned overseas, and whether it survives a US import ban the company cannot negotiate its way around. Furthest out, and least discussed this week, is what a register this concentrated does when lockups start expiring into a float this small. For now, the most useful way to hold Wednesday's numbers is to keep them separate. The company is real, profitable, and first in the world by humanoid shipments.

 

Unitree Robotics, formally Yushu Technology, listed on the Shanghai STAR Market under ticker 688836.SH on August 19, 2026. It issued 40.45 million shares at 150.80 yuan each, 10% of post-offering capital, raising 6.1 billion yuan (about $904 million) against a 4.2 billion yuan target. The stock opened at 1,100 yuan, up 629.44%, and closed at 845 yuan, up 460.34%.

That figure reflects the opening price only. Shares faded through the session to close at 845 yuan, a market capitalisation near 342 billion yuan or about $50 billion. At the 150.80 yuan offer price the company was valued around 61 billion yuan, roughly $9 billion. Treat the $66 billion as the peak of a first-minute print rather than a standing valuation.

Because it sets the price. After a 10% offering and lockups on strategic allocations, only about 7.4% of share capital trades freely. When roughly 9.8 million retail accounts bid for 9.7 million shares against that supply, the clearing price reflects scarcity rather than valuation, and the same structure creates supply pressure later when lockups expire.

Yes, and it is a rare profitable name in humanoid robotics. 2025 revenue was 1.708 billion yuan with net profit of 278.21 million and a 60.27% gross margin. But first-quarter 2026 adjusted net profit fell 52.55% year-on-year, and the company guides first-half adjusted net profit to decline 6.43% to 21.97% even as revenue grows 35.62% to 45.41%.

Wang holds about 121.4 million shares and 68.78% of voting rights. At the closing price the stake was worth roughly 103 billion yuan, with Reuters putting his paper wealth above $12 billion. It is locked and unrealised, so the figure moves with the share price.

Yes. Hangzhou DeepSeek Artificial Intelligence Basic Technology Research, founded by Liang Wenfeng, took 933,399 shares for about 141 million yuan as a strategic placement investor, 2.31% of the offering, with a strategic cooperation memorandum on embodied intelligence and AI models. The 36-month lockup means any gain stays on paper until 2029.

The Shanghai Composite fell around 2% to 2.4%, the CSI300 2.4%, and the STAR Market Composite 7.2%. Reuters attributed the selling to semiconductor and robotics weakness alongside soft corporate earnings and economic concerns. Rotation into the IPO may have contributed, but the decline was broad and Hong Kong-listed robotics names actually rose